Preclinical Studies Confirm NKAPL as Lung Cancer Tumor Suppressor, Prompt Demethylation Therapy Development

Findings that NKAPL halts tumor growth through TRIM21 stabilization with NF-κB inhibition have led researchers to advocate demethylation-based treatments